Not Yet Recruiting PHASE1 INTERVENTIONAL 1-arm
NCT07433335
A Study to Assess the Safety and Tolerabiliy of SR-878 in Patients With Rheumatoid Arthritis
Phase 1b Study to Assess the Safety and Tolerabiliy of SR-878 in Patients With Rheumatoid Arthritis
Sponsor: FGK Clinical Research GmbH
Conditions
Rheumatoid Arthritis
Interventions
SR-878
Updated 1 time since 2026 Last updated: Feb 24, 2026 Started: Mar 15, 2026 Primary completion: Feb 29, 2028 Completion: Feb 29, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1 clinical study on Rheumatoid Arthritis, this trial is actively recruiting participants. The trial is conducted by FGK Clinical Research GmbH and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- FGK Clinical Research GmbH
- SciRhom GmbH
Data source: SciRhom GmbH
For direct contact, visit the study record on ClinicalTrials.gov .